Effect of Intradialytic Eating Timing on Hemodynamic Stability and Dialysis Adequacy in Hemodialysis Patients
IDE-HD
The Effect of Differences in Intradialytic Eating Time on Hemodynamic Stability and Hemodialysis Adequacy in Patients With Chronic Kidney Disease Undergoing Hemodialysis
1 other identifier
interventional
40
1 country
1
Brief Summary
This study aims to examine how different meal timing during hemodialysis affects blood pressure stability and dialysis effectiveness in patients with chronic kidney disease. Many patients eat during hemodialysis sessions to maintain their nutritional status, but eating during treatment may affect blood pressure and the body's ability to remove toxins and excess fluid effectively. At present, there is no clear guideline about the safest and most effective time to eat during hemodialysis. This study will involve patients with chronic kidney disease who undergo regular hemodialysis. Participants will be divided into two groups: an intervention group and a control group. The intervention group will receive meals at different time points during hemodialysis sessions, while the control group will continue their usual eating habits without structured meal timing intervention. Blood pressure, heart rate, and mean arterial pressure will be measured repeatedly during dialysis sessions to assess hemodynamic stability. Dialysis adequacy will be evaluated using the Kt/V parameter. The results of this study are expected to identify the safest and most effective time for eating during hemodialysis in order to maintain stable blood pressure and ensure adequate dialysis treatment. This study is expected to provide evidence-based guidance for healthcare providers in managing intradialytic eating practices and improving patient safety, treatment quality, and clinical outcomes in hemodialysis care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 22, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 2, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 20, 2026
CompletedFirst Submitted
Initial submission to the registry
February 26, 2026
CompletedFirst Posted
Study publicly available on registry
March 11, 2026
CompletedMarch 11, 2026
March 1, 2026
11 days
February 26, 2026
March 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Systolic Blood Pressure
Systolic blood pressure (SBP), measured in millimeters of mercury (mmHg), was recorded during hemodialysis sessions to evaluate hemodynamic responses associated with different intradialytic eating times.
Baseline (start of hemodialysis) and every 30 minutes during each 4-hour hemodialysis session (sessions 1-4)
Diastolic Blood Pressure
Diastolic blood pressure (DBP), measured in millimeters of mercury (mmHg), was recorded during hemodialysis sessions to evaluate hemodynamic responses associated with different intradialytic eating times.
Baseline (start of hemodialysis) and every 30 minutes during each 4-hour hemodialysis session (sessions 1-4)
Mean Arterial Pressure
Mean arterial pressure (MAP), measured in millimeters of mercury (mmHg), was calculated from systolic and diastolic blood pressure measurements to assess circulatory stability during hemodialysis sessions.
Baseline (start of hemodialysis) and every 30 minutes during each 4-hour hemodialysis session (sessions 1-4)
Heart Rate
Heart rate, measured in beats per minute (bpm), was monitored during hemodialysis sessions to assess cardiovascular responses associated with different intradialytic eating times.
Baseline (start of hemodialysis) and every 30 minutes during each 4-hour hemodialysis session (sessions 1-4)
Secondary Outcomes (1)
Hemodialysis Adequacy (Kt/V)
At the end of each 4-hour hemodialysis session (sessions 1-4)
Study Arms (2)
Structured Intradialytic Eating Timing
EXPERIMENTALParticipants receive standardized meals during hemodialysis at predefined time points across four sessions: first hour, second hour, third hour, and fourth hour of the dialysis session. Hemodynamic parameters (systolic blood pressure, diastolic blood pressure, mean arterial pressure, and heart rate) are measured every 30 minutes during each session. Dialysis adequacy is evaluated using the Kt/V parameter to assess the effect of meal timing on hemodynamic stability and dialysis efficiency.
Standard Care (Control)
NO INTERVENTIONParticipants receive routine hemodialysis care without structured intradialytic eating timing. Patients continue their usual eating and drinking habits during dialysis according to standard clinical practice. Hemodynamic parameters and dialysis adequacy are measured using the same procedures and time intervals as the intervention group.
Interventions
A structured dietary timing intervention in which standardized meals are provided to participants during hemodialysis at predefined time points across four sessions: first hour, second hour, third hour, and fourth hour of the dialysis session. The nutritional content and portion size are standardized across sessions. The intervention is designed to evaluate the effects of meal timing on hemodynamic stability (blood pressure, mean arterial pressure, heart rate) and hemodialysis adequacy (Kt/V).
Eligibility Criteria
You may qualify if:
- Adults aged ≥ 18 years
- Diagnosed with chronic kidney disease (CKD)
- Undergoing regular maintenance hemodialysis
- Receiving hemodialysis on a routine schedule (e.g., twice weekly)
- Clinically stable during hemodialysis
- Able to eat orally during dialysis sessions
- Willing to participate and provide informed consent
You may not qualify if:
- Patients with pre-dialysis with acute or severe cardiovascular conditions,, those receiving enteral/parenteral nutrition, with cognitive impairment, or who refuse or withdraw informed consent will be excluded."
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fik Ums
Pacitan, East Java, 63572, Indonesia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Masking Details
- Not applicable. This is an open-label study due to the nature of the dietary timing intervention, which cannot be blinded to participants, care providers, or investigators.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 26, 2026
First Posted
March 11, 2026
Study Start
January 22, 2026
Primary Completion
February 2, 2026
Study Completion
February 20, 2026
Last Updated
March 11, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared due to ethical considerations, patient confidentiality, and the absence of a formal data-sharing framework for this single-center academic study. Data will be used solely for research, analysis, and publication purposes as approved by the ethics committee.